- Home
- UTMD vs TIL Comparison
UTMD vs TIL Comparison
Compare UTMD & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTMD
- TIL
- Stock Information
- Founded
- UTMD 1978
- TIL 2018
- Country
- UTMD United States
- TIL United States
- Employees
- UTMD N/A
- TIL N/A
- Industry
- UTMD Medical/Dental Instruments
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- UTMD Health Care
- TIL Health Care
- Exchange
- UTMD Nasdaq
- TIL Nasdaq
- Market Cap
- UTMD 177.4M
- TIL 177.1M
- IPO Year
- UTMD N/A
- TIL 2021
- Fundamental
- Price
- UTMD $55.14
- TIL $12.46
- Analyst Decision
- UTMD
- TIL Strong Buy
- Analyst Count
- UTMD 0
- TIL 5
- Target Price
- UTMD N/A
- TIL $100.67
- AVG Volume (30 Days)
- UTMD 10.6K
- TIL 71.5K
- Earning Date
- UTMD 10-23-2025
- TIL 11-13-2025
- Dividend Yield
- UTMD 2.21%
- TIL N/A
- EPS Growth
- UTMD N/A
- TIL N/A
- EPS
- UTMD 3.54
- TIL N/A
- Revenue
- UTMD $38,633,000.00
- TIL N/A
- Revenue This Year
- UTMD N/A
- TIL N/A
- Revenue Next Year
- UTMD N/A
- TIL N/A
- P/E Ratio
- UTMD $15.60
- TIL N/A
- Revenue Growth
- UTMD N/A
- TIL N/A
- 52 Week Low
- UTMD $51.26
- TIL $10.80
- 52 Week High
- UTMD $67.16
- TIL $42.79
- Technical
- Relative Strength Index (RSI)
- UTMD 36.68
- TIL 34.96
- Support Level
- UTMD $53.66
- TIL $13.53
- Resistance Level
- UTMD $58.15
- TIL $13.50
- Average True Range (ATR)
- UTMD 1.14
- TIL 1.30
- MACD
- UTMD -0.07
- TIL -0.11
- Stochastic Oscillator
- UTMD 31.24
- TIL 18.12
About UTMD Utah Medical Products Inc.
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.